what glp-1 is approved for sleep apnea Did You Know? The FDA has treatments moderate to severe obstructive (OSA) in adults with obesity. This breakthrough provides a new treatment option beyond traditional CPAP therapy Therapeutic Potential of Glucagon-like Peptide-1

Recently, however, there has been a growing trend of "microdosing" GLP-1s, a practice that involves using smaller-than-prescribed doses of these drugs

Research-context page covering laboratory information and careful research-use-only Retatrutide positioning

This includes reduced rates of acute decompensated liver failure and alcoholic hepatitis, although, notably, no significant difference was observed in the progression to cirrhosis within the study period (Wickramarachchi et al., 2025)

The Wegovy pill was also launched in the US as of early 2026, which is an oral version of the injection

GLP-1s may help with OA by: Reducing overall inflammation Protecting cartilage in your joints Helping people lose weight takes pressure off the knees and hips Making walking and movement easier over time Studies found that GLP-1 and SGLT2 medicines may lower the risk of needing a knee replacement (for OA), though results varied

Lillevang-Johansen M, Abrahamsen B, Jrgensen HL, et al